TAPT1-AS1

Across TCGA pan-cancer cohorts, TAPT1-AS1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TAPT1-AS1 data layer compared with 17 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher TAPT1-AS1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TAPT1-AS1 expression acts as an unfavorable survival marker.

BLCA are the cancer types where TAPT1-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.174	0.625	.023	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

TAPT1-AS1–BLCA (DFS)

Open the BLCA breakdown →